United States · Series B startup

Who invested in Magenta Therpeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2017, from 1 source

Latest round
Series B, $50MMay 2017
Investors
6
See who backed them

The rounds

  1. May 2017

Everyone who backed them

Casdin CapitalVC firm1round
Third Rock VenturesVC firm1round
Access IndustriesCorporate VC1round
Be The Match BioTherapiesInvestment firm1round
GV AtlasInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Magenta Therpeutics

Who invested in Magenta Therpeutics?

Magenta Therpeutics's investors include Casdin Capital, Third Rock Ventures, Access Industries, Partners HealthCare Innovation and Be The Match BioTherapies, and 1 more on record.

How much has Magenta Therpeutics raised?

Magenta Therpeutics has raised $50M across 1 round since 2017.

When did Magenta Therpeutics last raise?

Magenta Therpeutics's most recent round was a Series B of $50M in May 2017.

What was Magenta Therpeutics's biggest round?

Its most recent round, $50M in May 2017, is also its largest on record.

Who backed Magenta Therpeutics first?

Magenta Therpeutics's first round on record, in May 2017, was backed by Casdin Capital, Third Rock Ventures and Access Industries and 3 others.

What stage is Magenta Therpeutics at?

Magenta Therpeutics's latest named round is a Series B, in May 2017.

Where is Magenta Therpeutics based?

Magenta Therpeutics is based in the United States.

Companies like Magenta Therpeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.